Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CytomX hires Hoyoung Huh to chair board

This article was originally published in Scrip

Executive Summary

CytomX Therapeutics, a biotechnology company developing monoclonal antibody therapies, has appointed Dr Hoyoung Huh chair of the board of directors. Dr Huh currently serves as chair of Geron Corporation, and on the boards of Addex Pharmaceuticals and BayBio. He was previously CEO, president and chair of BiPar Sciences, which was acquired by Sanofi in 2009. Former CytomX chair Dr Charles Homcy, venture partner at Third Rock Ventures, will continue to serve on the board.

Advertisement

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC016596

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel